Clinical Trials · NCT07758231
Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics
- Phase
- Phase 1
- Recruitment status
- Not Yet Recruiting
- Sponsor
- University of Wisconsin, Madison
- Enrollment
- 5
- Start date
- Oct 2026
- Locations
- 1 site, United States
- Primary endpoint
- Maximum Ethanol Concentration (Cmax)